Changes to Russian e-cigarette regulations questioned

Apr.18.2023
Changes to Russian e-cigarette regulations questioned
CRPT, the operator of the "honest label" system, confirms no changes to their system due to e-cigarette additives ban in Russia.

On April 17th, in response to the "ban on e-cigarette additives," 2FIRSTS Moscow News Center interviewed Yuri Babinkov, the manager of the tobacco department of the "Honest Label" operation company, about the potential impact of changes to related regulatory legislation on the existing "Honest Label" system.


Yuri Babinkov | Image Source: 2FIRSTS


According to Yuri Babinkov, the manager of the tobacco department at the CRPT, ...


There will be no changes to the "honest labeling" requirements, as electronic cigarettes will be subject to mandatory labeling restrictions.


However, he stated that due to the fact that ЦРПТ company is affiliated with the state, he is unable to answer any further questions regarding trade.


According to reports, CRPT Company is the fully authorized operator of the "Honest Label" system in Russia, and is a state-owned enterprise of the Russian Federation. On November 30, 2022, the revised version of the Russian Federation's Product Circulation Control Act No. 2178 will come into effect, which mandates the use of a tracking system for "tobacco and nicotine-containing products, as well as nicotine-free products." Failure to operate such products with traceability labels will result in penalties under the Russian Federation's Administrative Violations Code and Criminal Code, depending on the severity of the offense.


Honest Label" is a Russian product tracking system that currently covers more than a dozen categories, including tobacco, food, drugs, tires, and textiles. The system was launched in 2018 and has been effective in regulating product quality. On December 15th, 2022, e-cigarettes containing nicotine oil were included in the "Honest Label" regulation.


Related Reading:


Russian nicotine product producers must apply for a license" - This bill has passed its first reading.


In One Day, Russian Flavor Ban Timeline and Background Sketch Passes Three Readings Through Bill


Russian Ban on E-Cigarette Flavorings to Take Effect on September 1; Full Proposal Attached. On April 11, Russia Will Hold First Discussion on Proposal to Ban Flavored E-Cigarettes.


Russia proposes a maximum fine of 500,000 rubles for selling electronic cigarettes to minors.


What is the progress of the ban on certain flavors in Russia's legislative process? Here is an overview of the legislative process in Russia.


Interview with Russian producer of nicotine products: The trend towards regulatory compliance is irreversible, and a complete ban on e-cigarettes is unlikely.


Expert Analysis Series:


Expert interpretation 1: Russia's ban on flavored e-cigarettes extends to all products, and specific standards for additives are yet to be disclosed.


Expert Analysis 2: Russia Sets Minimum Retail Price for E-Cigarette Products to Reduce Demand for Nicotine-Based Products.


Expert interpretation 3: Russia proposes to ban the online sale and offline display of electronic cigarettes, effective June 1.


Topic: Progress and Expert Analysis on Russia's Ban on E-Cigarette Flavors (click the image below to go to the article)



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Product | Philip Morris Japan Launches Ginza-Exclusive IQOS ILUMA i PRIME, Limited to 1,814 Units at First Global Flagship
Philip Morris Japan (PMJ) launched the IQOS ILUMA i PRIME Ginza Limited Model Set in Tokyo on September 4, 2026, alongside the opening of IQOS Flagship Ginza, the brand’s first global flagship store. The Oasis Blue edition is limited to 1,814 individually numbered units, with the figure derived from the store’s address at Ginza 1-8-14. The set also includes two Yamanaka-nuri glasses and special packaging, priced at JPY 11,980 and sold exclusively at the Ginza flagship.
Sep.07
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australia’s Coalition has unveiled a national illicit-tobacco policy that would cut tobacco excise by 80% and create legal, regulated and taxed adult markets for vaping products and nicotine pouches if it wins government. The plan proposes an excise of A$0.50 per millilitre of e-liquid and A$0.025 per milligram of nicotine in pouches, alongside A$200 million in additional enforcement and a A$60 million three-year public-awareness campaign. The Coalition says the package would narrow the price advantage of illicit products and undermine organised crime, while Labor and public-health groups warn that dramatically cheaper cigarettes could reverse long-term declines in smoking.
Sep.03
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23